Conditions and Diseases we treat

Thrombosis & Hemostasis

Our team is dedicated to treat children with bleeding and clotting problems. Team includes physicians, nurses and social workers, with special interest in hemophilia and coagulation factor deficiencies. We also dedicate our care to children with clotting disorders. Beyond the care of children afflicted with these conditions, we also consider family education, social interactions among families of affected children, home care and support as the goal of our team to help parents and families with their inevitable emotional challenges.

We engage in ongoing research for developing innovative therapies and for addressing safety issues, e.g. complications or risks that may be associated with medications. We educate and mentor future trainees in diagnosis and treatment of children and adolescents with bleeding and clotting disorders, and treatment.


Our team is dedicated to care for children with bleeding problems. We treat children with:

  • Congenital or acquired bleeding disorders:

    [Our Clinical TrialsPatient Information ]

    • Hemophilia A (Classical Hemophilia-factor VIII deficiency)
    • Hemophilia B (Christmas disease, factor IX deficiency)
    • Hemophilia C (Factor XI deficiency)
    • Von Willebrand’s disease


  • Rare clotting factor deficiencies:

    [Our Clinical TrialsPatient Information ]

    • Factor I (fibrinogen deficiency, known as afibrinogenemia or dysfibrinogenemia/hypofibrinogenemia)
    • Factor II (prothrombin)
    • Factor V (parahemophilia)
    • Factor VII
    • Factor X (Stuart factor)
    • Factor XII (Hageman factor)
    • Factor XIII


  • Disorders of the platelets:

    [Our Clinical TrialsPatient Information]

    • Hermansky-Pudlak syndrome
    • Wiskott Aldrich syndrome
    • Gray platelet syndrome
    • Alpha granule deficiency
    • Bernard Soulier Syndrome or disorders involving fibrinolytic system (e.g. PAI-I deficiency or alpha-2 antiplasmin deficiency)


  • Inherited Disorders of Thrombosis:

    [Our Clinical TrialsPatient Information ]

    • Protein C
    • Protein S
    • Anti-thrombin-III
    • Factor V Leiden
    • Prothrombin gene mutation
    • Anti-phospholipid antibodies
    • Lipoprotein-A
    • Homocysteinemia
    • Elevated fibrinogen
    • Factors VIII, IX, XI
    • Low factor XII

Unique Features:

  • All coagulation studies, platelet function tests, and thrombophilia tests are done at the “Special Hematology Laboratory” at Westchester Medical Center
  • Comprehensive Genetics Diagnostics
  • Comprehensive Hemophilia Network
  • Personalized and Customized Care


Research and Education Highlights:

  • We participate in clinical trials of new factor products which enables us to try new innovative therapies in children with hemophilia.
  • Student, resident and other allied health professional elective training


Key Contacts

Oya Tugal, MD
[email protected]
Phone: (914) 493-7997
Rose Bartone, LCSW-R
[email protected]
Phone: (914) 594-2159
Emily Thatcher, PA-C
[email protected]
(914) 493-7997